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Abstract 
 
This article focuses on the development of soft and hard infrastructures to support a life 
science ecology in a peripheral European city region. Liverpool City Region has received 
almost £1.7bn in capital investment through EU Cohesion Policy to redevelop the city region 
and reinvigorate its economy towards knowledge based industries. The analysis of the city 
regions life science ecology highlights the uneven development of hard and soft 
infrastructures.  Due to the diversity of firms within the region it has proven difficult to 
establish soft infrastructure related to scientific knowledge. The outcome has led to soft 
infrastructures being more business support orientated rather than scientific knowledge 
based, reducing inter-firm connections on a product or service basis. The evidence shows that 
not all types of soft infrastructure emerge as an outcome of investment. Hence, policy makers 
need to provide a clearer narrative on their investments, focusing on fewer core 
competencies rather than breadth of activities.  
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Introduction  
 
Governments and international organisations at all levels have seen the potential economic 
and social benefits that a strong regional life science industry can yield (Benneworth, 2002). 
Deloitte (2014) estimated that the global life science industry was worth over $1.5tn in 2012. 
If a region can develop appropriate hard infrastructures that enable the softer financial and 
knowledge flows associated with the industry to be captured, that may stimulate regional 
development. Drawing on this hard/ soft distinction from Colapinto & Porlezza (2012), this 
article explores investments in particular hard infrastructures that are seeking to support the 
development of soft life science infrastructures in peripheral city-regions. 
 
This article thus asks the research question of whether public investment in hard 
infrastructures can also stimulate the emergence of the soft infrastructures necessary for 
dynamic life science ecologies. The paper reports a case study from Liverpool, an old industrial 
region that shifted its economic development path from 1980s managed decline towards new 
creativity- and science-based industries. Drawing on primary qualitative data, the analysis 
highlights the problem of a cognitive distance barrier between firms.  The article concludes 
that building new hard infrastructure can under certain conditions further the development 
of a life science ecologies in a peripheral region. 
Ecologies: Life Sciences and Regional Development  
 
Economic development no longer depends on the availability of traditional production factors 
such as land, labour and capital, but also knowledge capital.  Where there are many firms that 
are active in the same kinds of knowledge fields, what Nooteboom (2000) calls cognitive 
proximity, then there can be positive linkages and feedback that produce increasing returns 
to scale.  These places are then attractive as investment opportunities for others. Kleppers 
(2010) argued that places serviced well by venture capitalists and/or business angels tend to 
foster more entrepreneurial activity. Business angels are individuals or collectives who 
provide capital for a business start-up, usually in exchange for convertible debt or ownership 
equity (Festel, 2011). They usually invest both money and their time to the venture. 
 
There has been much interest in the potential of life sciences as a quintessential knowledge-
intensive industry to drive regional economic development within regions including South 
East England, Scotland and Central England (Cooke, 2004; Kasabov, 2011) but also 
internationally (Cooke, 2004; Moodysson et al, 2008). Given the 5 to 15 year timescales that 
exist in the commercialisation of new products in this industry, there are potential gaps that 
exist in the funding models between start-up and phase one approval.  Life science firms in 
the USA and in Europe have noted that business angels are significant players in bridging the 
gaps between early start ups and raising the levels of capital needed to sustain a venture 
(Festel, 2011). Birch (2011) argues further, that less favoured regions tend to suffer from a 
lack of venture capital that is able to service innovations through to commercialisation. These 
analyses highlight a number of key factors underpinning successful life science-based 
development: 
(a) The presence of star scientists in research intensive universities (Zucker et al, 1998). 
(b)  Presence of government led research institutions (Klepper, 2010)  
(c) Highly successful firms can well serviced by venture capitalists can accelerate 
successful spin-outs (Festel, 2011) 
(d) A mix of star scientists, government institutions, venture capitalists and successful 
businesses collaborating with universities and public organisations (Cooke, 2004; 
Moodysson et al, 2008). 
We conceptualise these factors as hard and soft infrastructures (Colapinto and Porlezza, 
2012). Hard infrastructure are tangible structures such as roads, buildings, 
telecommunications and ports, whilst soft infrastructures are intangible such as networking, 
knowledge exchange, business environments, human capital and regional institutions. For 
these latter soft infrastructures, a greater cognitive distance (i.e. less cognitive proximity 
between actors) can reduce the overall benefits the soft infrastructures bring (Maskell et al, 
2006). In this article ‘ecology’ is used to conceptualise the life science development in LCR. 
Toulmin (1990:194) states: 
 
‘Once we begin to think in ecological terms, we shall soon learn that every niche or 
habitat is one of its own kind, and that it demands a call for a careful eye to its 
particular, local, and timely circumstances. The Newtonian view encouraged hierarchy 
and rigidity, standardisation and uniformity: an ecological perspective emphasises, 
rather, differentiation and diversity, equity and adaptability’  
 
Much literature here emphasised specific factors that have led to success, overlooking factors 
that may have hindered regional development been liabilities to the regions development. 
The ecological perspective focuses on the configuration of firms and infrastructures in 
studying how a life science region develops over time and how individual infrastructure 
configurations develop within their respective contexts (Tsoukas and Dooley, 2011). Where 
there are complementarities between knowledge infrastructures related to specific kinds of 
knowledge, skill and expertise and local actors, regions may develop innovation ecologies by 
stimulating knowledge networks and spaces whereby communities of practice can develop 
specifically to develop an innovation ecology (Coe et al, 2004:470; Shearmur, 2011). 
 
Method and Case: Liverpool City Region  
 
This paper seeks to answer the overall research question drawing on a case study of the 
Liverpool City Region in the North West of England (see figure 1). In 2014, LCR had an 
economy of 1.5 million people, 38,000 VAT registered businesses worth £25.3 billion to the 
UK economy and has been one of the fastest growing UK regions outside of London (LCRLEP, 
2014). Since the early 1990s, public money has been invested in developing new industries in 
the city-region (Southern, 2014). Recently, local institutions formulated a knowledge 
economy strategy identifying the life science industry as one of four key sectors for 
development. However, there has been no identifiable R&D activity in LCR by private 
pharmaceutical companies since 1961, supporting the rationale for public sector lead 
investment to support R&D.  
The case study explores the development and outcomes of hard and soft infrastructure within 
Liverpool City Region. The primary empirical evidence for this case study is drawn from 25 
semi-structured interviews with life science firms’ managers and supporting institutions at a 
local and national scale during 2012-13. The research used the Bionow (2012) industry 
directory verified via Companies House.  Secondary qualitative and quantitative data was 
used to supplement the analysis and inform the broader economic and industrial context.  
Figure 1 Liverpool City Region (Source: LCRLEP, 2014) 
 
An overview of Liverpool’s Life Science Ecology  
 
There is a diverse range of firm activity in the LCR life science ecology (see Table 1). At the 
time of writing, the 53 life science firms were active and present in LCR, giving a relatively 
small ecology compared to the South of England and USA. 
Table 1 Life Science firms by Activity in LCR 
Activity  Number of Firms in 2012 
Consultancy 7 
Discovery (R&D) 13 
Diagnostic 7 
Drug Manufacturing 9 
Medical Devices 8 
Other 9 
Total 53 
The majority of firms have registered locations in designated science or innovation park 
developments (see Figure 2).  These R&D sites are largely the result of publicly financed hard 
infrastructure developments. 
 
 
 
 R&D   Diagnostic/ Medical Devices   Manufacturing   Regional Asset 
Figure 2 Life science firms by location  
 
Alongside the firms are a set of organisations that are considered assets to the industry and 
which can hence be regarded as complementing the firm ecology.  The National Bio-
manufacturing Centre was completed in 2005 at a capital cost of £34m to provide facilities 
and infrastructure for life science related firms. It has subsequently attracted the largest 
concentration of pharmaceutical manufactures in Europe, making it a significant hard 
infrastructure development. Five further manufacturers are located outside the NBC, four of 
which are independent manufacturers that acquired sites already equipped with bespoke 
capabilities to increase operational capacity.  
 
Local policy-makers have attempted to put in place a strategy to diversify this ecology towards 
more knowledge-intensive and high value-added activities such as R&D. The most significant 
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additional R&D infrastructure intervention came through the development of MerseyBio 
Incubator located at the University of Liverpool in 2001.   In the interviews, the local policy 
makers identified a range of life science ‘assets’ in LCR; these are listed in Table 2 below along 
with their rationale for public support.  
Table 2 Regional Assets in the LCR Life Science Ecology 
Asset  Policy rationale  Issue 
University of Liverpool  Offers education and research 
across the biosciences, 
medicine, dentistry, health 
sciences, tropical medicine and 
veterinary science.   
The strategies recognise these 
assets are sources and 
infrastructures for innovation, 
spin-out firms and world leading 
research. All enrich the labour 
market with graduates. 
 
Graduate retention is low in the 
region. Employers in the sector 
cast doubt on the work readiness 
of graduates. 
 
Many jobs in the sector require 
post-graduate level education and 
training.  
Liverpool John Moore’s 
University  
Has a long record of expertise 
in teaching, research, 
consultancy and knowledge 
transfer partnerships in life 
sciences.  
Liverpool School of 
Tropical Medicine  
The first institution in the world 
dedicated to tropical disease. 
The institutions leads the field 
in research against infections, 
debilitating and disabling 
diseases.  
MerseyBio Incubator State-of-the-art facility for 
developing biotechnology 
businesses. Offers office and 
laboratory space with access to 
high value capital equipment.  
  
The facility has been managed by a 
consultancy firm with expertise in 
biotechnology commercialisation.  
 
Limited in size with 5 companies in 
2012.  
National Bio-
manufacturing Centre 
(NBC) 
Received £34 million capital 
investment to build state of the 
art manufacturing facilities and 
supporting infrastructures such 
as road and 
telecommunications.  
Largest concentration of 
pharmaceutical manufacturers in 
Europe. Hosts four multinational 
firms that are large employers in 
the region. 
 
No R&D activity recorded on this 
site since 1960’s. Seasonal 
production with limited linkages to 
city region firms.  
Royal Liverpool University 
Hospital  
Large provider of front line 
health services as well as being 
a centre of excellence and 
research for health issues such 
as cancer, neurology and 
pancreas translation research. 
Undergoing £600 million rebuild 
designed to integrate bioscience 
infrastructures. 
 
Suffered delays due to changes in 
national government. Due for 
completion in summer 2017. 
 Towards a life science Ecology in Liverpool. 
 
In LCR the development of infrastructures has seen a clear split between hard and soft 
infrastructures. Firstly, investment came in developing hard infrastructures such as 
MerseyBio incubator, science parks and road network improvements. Secondly, there has 
been substantial attention for the development of soft infrastructures such as networking, 
business support, scientific knowledge exchange, human capital and institutional bodies.  
 
MerseyBio incubator encountered problems diversify the industry towards commercial R&D, 
with a perception that local universities were not full exploiting the commercial potential of 
their intellectual property in the life sciences. Primarily, scientists were reluctant to spin-out 
of the university and form a company due to perceived risks in investment. Furthermore, the 
universities lacked softer infrastructures to facilitate the spin-out process, supporting the 
commercialisation of IP and attracting new investment.  Respondents attributed this primarily 
to underlying issues of control and ownership.  
 
“This idea of spin-outs or doing something with your IP was something that sat there 
and you know people had it in documents but it was never, ever taken seriously.  I think 
that was part of the problem.” (Consultancy Firm 3, 09/05/12)  
 
LCR is not well served by venture capitalists or business angels. The majority of R&D firms 
stated they had received funding from national, regional and local government grants, that 
compensate for a lack of private funding available, but that do not come with sector specific 
investors who bring their own soft infrastructures. 
 
“So people have to find it [money] somewhere.  In the past people would look at a 
mixture, so it would be their own money, plus grants, plus some VC money.  I don’t 
think the VC money’s been particularly good for life sciences in the North West let alone 
Liverpool.” (Consultancy Firm 1 26/06/12) 
 
Furthermore, there has been be a mismatch between the quality of research and the level of 
funding available. As one participant commented: 
 
“The science is normally terrific, the enthusiasm is unmatched, but it’s matching money 
with the damp and hard edged enthusiasm of business, which is the hardest piece.” 
(Discovery Firm 5 15/08/12) 
 
The 13 identified R&D firms are highly specialised and at various stages of development, with 
no identifiable inter-firm connections on a product or services bases, a high ‘’cognitive 
distance” in Nooteboom’s terminology.  The high fragmentation of life sciences activities 
shown in Table 1 and their highly specialised nature led to an inability to share knowledge, 
research focus and connections. Hence, firms must look beyond the ecology (e.g. attending 
conferences elsewhere) to build soft infrastructures and secure scientific knowledge assets 
and inputs. These tend to be held in the larger life science ecologies such as Cambridge (UK) 
or Boston (USA) with comparatively more firms, specialised in fewer subsectors or types of 
R&D. These regions have life science related hard and soft infrastructures in which Liverpool 
life science firms seek to temporarily participate to acquire knowledge assets.  In short, 
despite over 15 years of public investment, the LCR is not recognised as a ‘place to be’ for life 
sciences in comparison to other regions.  
 
“There seems to be a lack of awareness of what’s in the North West [which includes LCR] 
because when you say life sciences people are drawn to think of London and Oxbridge 
because of their reputations” (Public Organisation 2, 05/08/12) 
 
Despite the hard infrastructures projects, the absence of international awareness further 
undermines the development of soft scientific knowledge based infrastructures. However, 
what is developing are soft business support infrastructures related to common problems 
faced by firms. 
 
‘Now they’re [other firm] in completely different areas to us, but it shouldn’t actually 
matter whether they’re in different areas or not… we share common issues, we’re 
going to have issues around funding, we’re going to have issues around facilities, we’re 
going to have issues around staff, we’re going to have issues around the perception of 
the industry nationally and, national policy that’s going to allow the industry to thrive.  
So it’s important that those sort of links are engendered.” (Discovery Firm 2, 23/10/12) 
 
Concluding Discussion 
 
The development of hard and soft infrastructures has been uneven in LCR. The hard 
infrastructures are expensive but have been easy to promote for policy makers and have 
supported the development of LCR so far. In comparison soft infrastructures are potentially 
inexpensive, but are harder to achieve in ways that help to make the region more attractive 
to knowledge and capital flows. The type of soft infrastructure that has developed is non-
scientific relating to business support. Given the diversity of firm it has been difficult to 
develop scientific soft infrastructures relating to research and knowledge exchange for 
product development.  
 
This paper has sought to explore how soft life science infrastructures emerge and contribute 
to the ecology’s development. The soft infrastructures identified here have not been 
publically funded but were outcomes of bringing people together in hard infrastructure 
projects such as science parks. Although the level of funding available has not increased and 
at the same time government funding has become more centralised, these comparatively 
inexpensive soft infrastructures are highly valuable to the ecology’s continued development.  
 
Unlike other peripheral regions that saw scientific soft infrastructure emerge (Benneworth, 
2002), not all ecologies can develop scientific soft infrastructures through funding hard 
infrastructure investment alone. Hard and soft infrastructure configurations need to provide 
a clear narrative, specialising in fewer core competencies rather than breadth of activities. In 
particular, further investment and support of the soft infrastructures, locally and extra-locally, 
can be used as a measure to further reduce the cognitive distance in the ecology and further 
the scientific soft infrastructures.   
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